These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24378739)

  • 1. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse.
    Myint T; Anderson AM; Sanchez A; Farabi A; Hage C; Baddley JW; Jhaveri M; Greenberg RN; Bamberger DM; Rodgers M; Crawford TN; Wheat LJ
    Medicine (Baltimore); 2014 Jan; 93(1):11-18. PubMed ID: 24378739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interruption of antifungal secondary prophylaxis in AIDS-related histoplasmosis].
    Negroni R; Helou SH; López-Daneri G; Robles AM; Arechavala AI; Bianchi MH
    Rev Iberoam Micol; 2004 Jun; 21(2):75-8. PubMed ID: 15538831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy.
    Goldman M; Zackin R; Fichtenbaum CJ; Skiest DJ; Koletar SL; Hafner R; Wheat LJ; Nyangweso PM; Yiannoutsos CT; Schnizlein-Bick CT; Owens S; Aberg JA;
    Clin Infect Dis; 2004 May; 38(10):1485-9. PubMed ID: 15156489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.
    Hecht FM; Wheat J; Korzun AH; Hafner R; Skahan KJ; Larsen R; Limjoco MT; Simpson M; Schneider D; Keefer MC; Clark R; Lai KK; Jacobson JM; Squires K; Bartlett JA; Powderly W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):100-7. PubMed ID: 9358104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels.
    Wheat LJ; Connolly-Stringfield P; Blair R; Connolly K; Garringer T; Katz BP
    Ann Intern Med; 1991 Dec; 115(12):936-41. PubMed ID: 1952490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay.
    Hage CA; Kirsch EJ; Stump TE; Kauffman CA; Goldman M; Connolly P; Johnson PC; Wheat LJ; Baddley JW
    Clin Vaccine Immunol; 2011 Apr; 18(4):661-6. PubMed ID: 21307278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals.
    Tobón AM; Agudelo CA; Rosero DS; Ochoa JE; De Bedout C; Zuluaga A; Arango M; Cano LE; Sampedro J; Restrepo A
    Am J Trop Med Hyg; 2005 Sep; 73(3):576-82. PubMed ID: 16172484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras.
    Peigne V; Dromer F; Elie C; Lidove O; Lortholary O;
    Am J Trop Med Hyg; 2011 Nov; 85(5):934-41. PubMed ID: 22049053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS).
    McKinsey DS; Gupta MR; Riddler SA; Driks MR; Smith DL; Kurtin PJ
    Ann Intern Med; 1989 Oct; 111(8):655-9. PubMed ID: 2802421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
    Wheat J; Hafner R; Wulfsohn M; Spencer P; Squires K; Powderly W; Wong B; Rinaldi M; Saag M; Hamill R; Murphy R; Connolly-Stringfield P; Briggs N; Owens S;
    Ann Intern Med; 1993 Apr; 118(8):610-6. PubMed ID: 8383934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system histoplasmosis. An unappreciated complication of the acquired immunodeficiency syndrome.
    Anaissie E; Fainstein V; Samo T; Bodey GP; Sarosi GA
    Am J Med; 1988 Feb; 84(2):215-7. PubMed ID: 3407651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system histoplasmosis: Multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment.
    Wheat J; Myint T; Guo Y; Kemmer P; Hage C; Terry C; Azar MM; Riddell J; Ender P; Chen S; Shehab K; Cleveland K; Esguerra E; Johnson J; Wright P; Douglas V; Vergidis P; Ooi W; Baddley J; Bamberger D; Khairy R; Vikram HR; Jenny-Avital E; Sivasubramanian G; Bowlware K; Pahud B; Sarria J; Tsai T; Assi M; Mocherla S; Prakash V; Allen D; Passaretti C; Huprikar S; Anderson A
    Medicine (Baltimore); 2018 Mar; 97(13):e0245. PubMed ID: 29595679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of the treatment and secondary antifungal prophylaxis in AIDS-related histoplasmosis. Experience at the Francisco J. Muñiz Infectious Diseases Hospital in Buenos Aires].
    Negroni R; Messina F; Arechavala A; Santiso G; Bianchi M
    Rev Iberoam Micol; 2017; 34(2):94-98. PubMed ID: 28391953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil.
    Damasceno LS; Ramos AN; Alencar CH; Gonçalves MV; de Mesquita JR; Soares AT; Coutinho AG; Dantas CC; Leitão Tdo M
    Mycoses; 2014 Jul; 57(7):406-13. PubMed ID: 24612078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Nervous System Histoplasmosis in Acquired Immunodeficiency Syndrome.
    Nyalakonda H; Albuerne M; Suazo Hernandez LP; Sarria JC
    Am J Med Sci; 2016 Feb; 351(2):177-86. PubMed ID: 26897273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated histoplasmosis in an AIDS patient with immunologic non-response to HAART: A case report.
    Adekanmbi O; Nwanji I; Oladele R
    J Mycol Med; 2022 Aug; 32(3):101271. PubMed ID: 35298932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome.
    Norris S; Wheat J; McKinsey D; Lancaster D; Katz B; Black J; Driks M; Baker R; Israel K; Traeger D
    Am J Med; 1994 Jun; 96(6):504-8. PubMed ID: 8017447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful discontinuation of secondary prophylaxis for histoplasmosis after highly active antiretroviral therapy.
    Sun HY; Chen MY; Hsieh SM; Hung CC; Chang SC
    J Formos Med Assoc; 2004 Jul; 103(7):546-8. PubMed ID: 15318277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis.
    Wheat LJ; Connolly-Stringfield P; Blair R; Connolly K; Garringer T; Katz BP; Gupta M
    Am J Med; 1992 Feb; 92(2):153-60. PubMed ID: 1543199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful discontinuation of high-dose fluconazole for Histoplasma capsulatum meningitis in an AIDS patient after sustained immune reconstitution.
    Jenny-Avital E
    Clin Infect Dis; 2004 Oct; 39(8):1261-2. PubMed ID: 15486865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.